The presence of gastrointestinal (GI) symptoms does not appear to significantly contribute to any clinical outcomes in adult patients admitted for COVID-19, reveals a retrospective study in the Philippines.
Although both the BNT162b2 and ChAdOx1 nCoV-19 vaccines appear to be effective against symptomatic disease caused by the delta variant of the SARS-CoV-2 virus, the effectiveness is lower than that against the alpha variant. However, this reduced effectiveness was less pronounced after two doses of the vaccine, a recent study from England showed.
Concomitant or sequential administration of the combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine and the tetravalent dengue vaccine (CYD-TDV; sold under the brand name Dengvaxia) produces similar immunogenicity and safety profiles in baseline dengue seropositive participants, a Philippines study has shown.
The use of the anti-inflammatory drug colchicine in an outpatient setting may reduce the risk of COVID-19–related death or hospitalization in patients with PCR-confirmed COVID-19, according to results of the phase III COLCORONA* trial.
The installation of a decentralized contact tracing app (CTA) for COVID-19 is driven by concern for one’s own health, but concern for others does not significantly predict app uptake over and above self-focused concern, a recent study suggests.
More than 8 months since the first COVID-19 vaccine is made available to the masses, the world has held the hope of a return to normalcy just to see it dashed again with the recent surge in COVID-19 cases.
Wearing a surgical face mask provides a high protective effect against aerosols while posing low airflow resistance, in contrast to plastic face shields which offer little to no protection, a study reveals.